News
Ceribell, Inc. CBLL recently announced that it has received FDA clearance for the Clarity algorithm for use in pediatric patients. This breakthrough expands the utility of Ceribell’s rapid ...
The latest clearance allows Ceribell to apply its Clarity algorithm to data captured by the headbands to detect electrographic seizures in children. Ceribell raised $207.3 million in an initial ...
FDA clearance of Ceribell’s Clarity™ algorithm will enable rapid, bedside detection, diagnosis, and treatment of non-convulsive seizures in children experiencing neurological emergencies.
Ceribell, Inc. CBLL recently announced that it has received FDA clearance for the Clarity algorithm for use in pediatric patients. This breakthrough expands the utility of Ceribell’s rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results